Clinical Trial Update: Effects of Talampanel on Patients With Advanced Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Talampanel was studied in patients with advanced Parkinson's disease and dyskinesias in a Phase 1/2 trial that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia
• Parkinson Disease

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Dyskinesias, Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED